Send to

Choose Destination
J Infect Dis. 2003 Dec 15;188(12):1885-91. Epub 2003 Dec 8.

P fimbria-specific B cell responses in patients with urinary tract infection.

Author information

Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.


Local immune response may be important in defense against urinary tract infection (UTI). P fimbria, an important virulence factor of Escherichia coli, is a noteworthy candidate for use in a vaccine against pyelonephritis (PN). Eleven patients with PN and 14 patients with lower urinary tract infection (LUTI) caused by E. coli were studied for mucosa-derived antibody-secreting cells (ASCs) and for urinary antibodies. In the 10 patients with P-fimbriated (P+) E. coli, an ASC response to P fimbria was found in 5 of 5 patients who had PN and 1 of 5 patients who had LUTI. The response to P fimbria was stronger among patients with P+ PN than among patients with PN caused by non-P-fimbriated E. coli (P-) (P<.001) or patients with P+ LUTI (P<.001). The response to P fimbria was also stronger than the response to outer-membrane protein A among all patients with PN. P fimbria-specific urinary immunoglobulin A antibody levels were higher among patients with P+ PN than those with P- PN. The results show a P fimbria-specific local immune response, which further encourages the use of P fimbria in locally administrable UTI vaccines.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center